
Sign up to save your podcasts
Or
Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.
NCPD information and select publications here.
4.9
5252 ratings
Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.
NCPD information and select publications here.
17 Listeners
32 Listeners
16 Listeners
62 Listeners
12 Listeners
73 Listeners
0 Listeners
315 Listeners
39 Listeners
110 Listeners
478 Listeners
55 Listeners
1,085 Listeners
196 Listeners
44 Listeners
21 Listeners
513 Listeners
165 Listeners
37 Listeners